Inventor · disambiguated record
Susan M. Freier
Also filed as: FREIER SUSAN · FREIER SUSAN J · FREIER SUSAN M
249 granted patents·266 pending applications·4,232 citations·filing 1992–2025
99Inventor score
Files withIONIS PHARMACEUTICALS INC218ISIS PHARMACEUTICALS INC156BENNETT C FRANK17FREIER SUSAN M16REGULUS THERAPEUTICS INC12
Top patents by PatentIndex Score
515 records- 0199US8110558B2Oligomeric compounds and compositions for use in modulation of small non-coding RNASBENNETT C FRANK·Filed 2008·Granted Feb 7, 2012·61 cites·25 claims
- 0299US8106025B2Method for inhibiting the activity of mir-155BENNETT C FRANK·Filed 2008·Granted Jan 31, 2012·45 cites·22 claims
- 0399US7217572B2Modulation of HIF1α and HIF2α expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted May 15, 2007·139 cites·18 claims
- 0499US6287860B1Antisense inhibition of MEKK2 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 11, 2001·334 cites·14 claims
- 0598US8546350B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsBENNETT C FRANK·Filed 2012·Granted Oct 1, 2013·35 cites·22 claims
- 0698US8415465B2Compositions and their uses directed to huntingtinFREIER SUSAN M·Filed 2011·Granted Apr 9, 2013·40 cites·26 claims
- 0798US8133876B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsBENNETT C FRANK·Filed 2008·Granted Mar 13, 2012·44 cites·17 claims
- 0898US7951934B2Compositions and their uses directed to huntingtinISIS PHARMACEUTICALS INC·Filed 2007·Granted May 31, 2011·51 cites·23 claims
- 0998US7622455B2Methods for slowing familial ALS disease progressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Nov 24, 2009·42 cites·20 claims
- 1098US7235653B2Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinISIS PHARMACEUTICALS INC·Filed 2003·Granted Jun 26, 2007·117 cites·11 claims
- 1198US6210892B1Alteration of cellular behavior by antisense modulation of mRNA processingISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 3, 2001·358 cites·31 claims
- 1297US9353372B2Compositions and their uses directed to huntingtinIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 31, 2016·16 cites·19 claims
- 1397US9057066B2Compositions and their uses directed to huntingtinISIS PHARMACEUTICALS INC·Filed 2012·Granted Jun 16, 2015·37 cites·17 claims
- 1497US8697663B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsBENNETT C FRANK·Filed 2008·Granted Apr 15, 2014·26 cites·28 claims
- 1597US8642752B2Modulation of Hepatitis B virus (HBV) expressionSWAYZE ERIC E·Filed 2012·Granted Feb 4, 2014·41 cites·37 claims
- 1697US8258109B2Compositions and methods for modulation of LMNA expressionBENNETT C FRANK·Filed 2006·Granted Sep 4, 2012·44 cites·17 claims
- 1797US8093222B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2009·Granted Jan 10, 2012·46 cites·68 claims
- 1897US7902163B2Antisense modulation of superoxide dismutase 1, soluble expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 8, 2011·34 cites·17 claims
- 1997US7399853B2Modulation of glucagon receptor expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 15, 2008·105 cites·26 claims
- 2097US7339051B2Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)ISIS PHARMACEUTICALS INC·Filed 2004·Granted Mar 4, 2008·158 cites·18 claims
- 2196US11834660B2Compositions for modulating Ataxin 2 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·2 cites·23 claims
- 2296US10006027B2Methods for modulating Ataxin 2 expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jun 26, 2018·21 cites·30 claims
- 2396US9765338B2Modulation of dystrophia myotonica-protein kinase (DMPK) expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·67 cites·24 claims
- 2496US9695418B2Oligomeric compounds comprising bicyclic nucleosides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 4, 2017·36 cites·17 claims
- 2596US8957040B2Selective reduction of allelic variantsBENNETT C FRANK·Filed 2011·Granted Feb 17, 2015·42 cites·16 claims
- 2696US8952145B2Compositions and their uses directed to huntingtinISIS PHARMACEUTICALS INC·Filed 2013·Granted Feb 10, 2015·23 cites·20 claims
- 2796US8697860B1Diagnosis and treatment of diseaseISIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 15, 2014·25 cites·16 claims
- 2896US8178506B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsLOLLO BRIDGET·Filed 2008·Granted May 15, 2012·37 cites·21 claims
- 2995US10815480B2Modulation of alpha synuclein expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·7 cites·20 claims
- 3095US10337007B2Oligomeric compounds comprising bicyclic nucleotides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2018·Granted Jul 2, 2019·6 cites·9 claims
- 3195US9914922B2Oligomeric compounds comprising bicyclic nucleotides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2013·Granted Mar 13, 2018·14 cites·12 claims
- 3295US9567587B2Antisense modulation of GCCR expressionIONIS PHARMACEUTICALS INC·Filed 2014·Granted Feb 14, 2017·30 cites·24 claims
- 3395US9399774B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 26, 2016·13 cites·40 claims
- 3495US9273315B2Modulation of huntingtin expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·19 cites·14 claims
- 3595US9006198B2Selective reduction of allelic variantsBENNETT C FRANK·Filed 2011·Granted Apr 14, 2015·36 cites·20 claims
- 3695US8084437B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2007·Granted Dec 27, 2011·44 cites·19 claims
- 3795US7803930B2Antisense modulation of apolipoprotein B-expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Sep 28, 2010·40 cites·36 claims
- 3895US7678895B2Antisense modulation of superoxide dismutase 1, soluble expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 16, 2010·28 cites·34 claims
- 3995US7563884B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 21, 2009·67 cites·28 claims
- 4095US7511131B2Antisense modulation of apolipoprotein B expressionGENZYME CORP·Filed 2003·Granted Mar 31, 2009·169 cites·57 claims
- 4195US7321828B2System of components for preparing oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 22, 2008·216 cites·4 claims
- 4295US6455308B1Antisense modulation of serum amyloid A4 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Sep 24, 2002·69 cites·26 claims
- 4394US10954519B2Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Mar 23, 2021·5 cites·24 claims
- 4494US10517953B2Modulators of PCSK9 expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·5 cites·10 claims
- 4594US10017764B2Oligomeric compounds comprising bicyclic nucleotides and uses thereofFREIER SUSAN M·Filed 2012·Granted Jul 10, 2018·10 cites·10 claims
- 4694US9957292B2Compositions and methods for modulating angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·11 cites·81 claims
- 4794US9382540B2Compositions and methods for modulating angiopoietin-like 3 expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·13 cites·28 claims
- 4894US9340784B2Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2013·Granted May 17, 2016·11 cites·14 claims
- 4994US9061044B2Modulation of transthyretin expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·14 cites·3 claims
- 5094US8946179B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsBENNETT C FRANK·Filed 2012·Granted Feb 3, 2015·12 cites·21 claims
Showing the top 50 of 515 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Susan M. Freier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →